The session will build on Real Voices, Better Choices, a new whitepaper commissioned by Boehringer Ingelheim and developed with input from more than 50 advocacy groups across the globe. It examines the role of lived experience in policymaking for NCDs and mental health, with case studies and space for meaningful exchange between those shaping policy and those most affected by it.